Stock Market Today: Disney Earnings Keep Dow, S&P Afloat
Impressive quarterly results from Disney helped offset a sharp drop in consumer confidence.
![Disney sign](https://cdn.mos.cms.futurecdn.net/9YFAVPmP2jiynaRbGMH478-415-80.jpg)
Stocks were choppy in today's low-volume session, as investors balanced another strong round of earnings against a dismal reading on consumer confidence.
In terms of earnings, Walt Disney (DIS, +1.0%) gained the bulk of headlines after reporting a fiscal third quarter with much higher-than-expected earnings, revenues and Disney+ subscriber numbers.
"The streaming story for Disney remains intact," says Carter Henderson, portfolio specialist and director of institutional development at Fort Pitt Capital Group. Results from Disney's parks and entertainment segment were strong, too, achieving "positive profits when many analysts didn't expect profitability to return until later in 2021 or even next year," per Henderson.
![https://cdn.mos.cms.futurecdn.net/hwgJ7osrMtUWhk5koeVme7-200-80.png](https://cdn.mos.cms.futurecdn.net/hwgJ7osrMtUWhk5koeVme7-320-80.png)
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
But this good news was tempered by data from the University of Michigan, which showed consumer confidence plunged to 70.2 in August – its lowest reading since April 2020 – with those surveyed expressing concern over unemployment, inflation and the quickly spreading delta variant.
Still, the Dow Jones Industrial Average (+0.04% to 35,515) and S&P 500 Index (0.2% to 4,468) managed to end the week at new highs.
Other news in the stock market today:
- The Nasdaq Composite eked out a 0.04% gain to 14,822.
- Several pharmaceutical stocks moved higher today, after the Food and Drug Administration authorized COVID-19 vaccine booster shots in immunocompromised individuals, including those with HIV and cancer. Among the names getting a lift were Pfizer (PFE, +2.6%), BioNTech (BNTX, +0.9%) and Johnson & Johnson (JNJ, +0.5%).
- Food delivery firm DoorDash (DASH, +3.5%) gained ground in the wake of its second-quarter earnings report. DASH said gross order volume surged 70% from the year prior to $10.5 billion, while revenue jumped 83% to $1.2 billion and adjusted EBITDA (earnings before interest, taxes, depreciation and amortization). While these figures were higher than analysts were expecting, DASH did say in its shareholder letter that it "anticipates a seasonal decline in new consumer acquisition and order rates in Q3."
- U.S. crude oil futures slipped 0.9% to settle at $68.44 per barrel.
- Gold futures gained 1.5% to finish at $1,778.20 an ounce.
- The CBOE Volatility Index (VIX) retreated 0.9% to 15.45.
- Bitcoin rose 4.6% to $46,476.13. (Bitcoin trades 24 hours a day; prices reported here are as of 4 p.m. each trading day.)
Don't Sweat the Small-Cap Underperformance
In the back of the pack today were small caps, with the Russell 2000 slipping 0.9% to 2,223. This is nothing new, with small caps lagging their larger-cap brethren dramatically over the past six months.
Scott Wren, senior global market strategist at Wells Fargo Investment Institute, says it's nothing to fear, and this underperformance is likely due to the "market getting concerned that future growth expectations are not going to pan out" as a result of a resurgence in COVID-19 cases.
"From our view, this small-cap underperformance is a temporary stumble," Wren adds.
For those investors who share this view that small caps will eventually bounce, we've recently compiled a list of the best small-cap stocks to buy, according to the pros.
And for those who want to add a little oomph to their portfolios, may we suggest these small-cap dividend stocks. While not typically known as income-building investments, this list of names offer hefty payouts for shareholders.
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
With over a decade of experience writing about the stock market, Karee Venema is the senior investing editor at Kiplinger.com. She joined the publication in April 2021 after 10 years of working as an investing writer and columnist at Schaeffer's Investment Research. In her previous role, Karee focused primarily on options trading, as well as technical, fundamental and sentiment analysis.
-
Who Will Be the Beneficiaries of Your Wealth?
Deciding who you want to inherit your wealth, as well as when and how, is a crucial first step in estate planning. Here are the four beneficiaries to keep in mind.
By Adam Frank Published
-
Visa Is the Worst Dow Stock Wednesday. Here's Why
Visa stock is down sharply Wednesday after the credit card company came up short of revenue expectations for its fiscal Q3.
By Joey Solitro Published
-
Stock Market Today: Stocks Tumble on Disappointing Big Tech Earnings
Poorly received quarterly results from Alphabet and Tesla sparked a steep selloff in equities.
By Dan Burrows Last updated
-
Stock Market Today: Mega-Cap Tech Rallies to Drag Markets Higher
Markets focused on upcoming earnings from Magnificent 7 stocks rather than chaos in D.C.
By Dan Burrows Published
-
Stock Market Today: Stocks Tumble After Spectacular Global Internet Crash
Market participants rushed out of risk assets to end a wild week of trading.
By Dan Burrows Published
-
Stock Market Today: Dow Sinks 533 Points as Big Banks, Mega Caps Slump
Goldman Sachs and Apple were two of the worst-performing blue chip stocks on Thursday.
By Karee Venema Published
-
Stock Market Today: Semis Get Slammed and Blue Chips Bounce
The potential for more curbs on tech sales to China set off a rotation into blue chips.
By Dan Burrows Published
-
Stock Market Today: Dow Spikes 742 Points After UnitedHealth Earnings
The S&P 500 and Nasdaq also scored wins Tuesday albeit with much smaller gains than the blue chip Dow.
By Karee Venema Published
-
Stock Market Today: Dow Adds 210 Points as Apple, Goldman Hit New Highs
A big rally in blue chips and some dovish Fed speak boosted the equities market Monday.
By Karee Venema Published
-
Stock Market Today: Markets Bounce Back on Rate-Cut Optimism
The latest readings on consumer sentiment and inflation helped lift the odds of the Fed easing in September.
By Dan Burrows Published